Article
Real-world genomic profiling of acute myeloid leukemia and the impact of European LeukemiaNet risk stratification 2022 update.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Dec 2023
da Rosa Susana Elaine Alves, de Lima Larissa Barbosa, Silveira Caroline Nunes, Cortes Luiz Gustavo Ferreira, de Oliveira Filho João Bosco, de Souza Reis Rodrigo, Cervato Murilo Castro, Rodrigues Pedro Henrique Sebe, de Oliveira Pelegrino Karla, Petroni Roberta Cardoso, da Silva Araujo Erica, Campregher Paulo Vidal
Abstract excerpt
BACKGROUND: Acute myeloid leukemia (AML) is a myeloid neoplasm associated with a high morbidity and mortality. The diagnosis, risk stratification and therapy selection in AML have changed substantially in the last decade with the progressive incorporation of clinically relevant molecular markers. METHODS: In this work, our aim was to describe a real-world genomic profiling experience in AML and to demonstrate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.